GRTS
Gritstone Oncology Inc
NASDAQ: GRTS · HEALTHCARE · BIOTECHNOLOGY
$0.03
+0.00% today
Updated 2026-04-30
Market cap
$3.80M
P/E ratio
—
P/S ratio
0.26x
EPS (TTM)
$-1.09
Dividend yield
—
52W range
$0 – $0
Volume
—
Gritstone Oncology Inc (GRTS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-15.29M | $-34.97M | $-38.16M | $-85.01M | $-89.10M | $-50.68M | $-115.95M | $-121.65M |
| Capital expenditures | $6.98M | $11.52M | $5.66M | $16.17M | $3.52M | $5.46M | $5.87M | $4.57M |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $597000.00 | $1.13M | $3.00M | $5.30M | $7.11M | $10.55M | $12.56M | $11.62M |
| Free cash flow | $-22.28M | $-46.49M | $-43.83M | $-101.18M | $-92.62M | $-56.14M | $-121.82M | $-126.22M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | $890000.00 | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $13.18M | $5.22M | $112.65M | $-60.47M | $-45.81M | — |